Best defense and space stocks to buy from India (June 2026): primes, defense-tech, space

Four political events have rewritten the defense-equity setup in twelve months:

June 24-25, 2025 (NATO Hague Summit): All NATO members except Spain committed to 3.5% of GDP on core defence + 1.5% on defence-adjacent spending by 2035 — a 5% combined pledge that is unprecedented in NATO's history.

April 2026 (Trump FY 2027 budget request): $1.5 trillion topline — $1.1 trillion base discretionary + $350 billion through reconciliation — a 42% increase over FY 2026 enacted. The administration also renamed "Department of Defense" to "Department of War" (DoW) in official filings.

April 24, 2026 (Golden Dome named contractors): Space Force named 12 companies for space-based interceptor (SBI) prototype development under up to $3.2 billion in combined OTAs for Trump's homeland missile defense program. Lockheed and Northrop are primes; Anduril is on the list; SpaceX gets a separate $2 billion contract for a 600-satellite missile-tracking constellation. Total Golden Dome cost estimate rose to $185 billion in March 2026.

March 2026 (Iran war escalation): Defense stocks spiked on day one (NOC +5-6%, RTX +4.5%, LMT new ATH at $676.70), then ITA −12% from start-March through April as RTX and LMT missed Q1 guidance. Stocks recovered as Q2 contract activity ramped. The "buy the war" thesis is more nuanced than the headlines suggest.

Together these four events have produced the cleanest "structural government demand" thematic of 2026. The complication, and the reason this guide exists: defense is backlog-driven, not run-rate driven. Lockheed missed Q1 2026 revenue and EPS — and the stock held because the $186.4 billion backlog is what matters. Defense investors who size positions off quarterly numbers will buy and sell at exactly the wrong moments.

This guide is for the Indian-resident investor who wants real defense and space exposure into the largest peacetime US defense budget in history. The honest answer for most readers: own the primes for backlog visibility, add Palantir if you can stomach the 150-200× multiple, hedge with one space pure-play, and recognize that Anduril (the most cited defense-tech name) is private at a $30.5 billion valuation and not accessible to retail at all.

What this guide is and isn't

It is: 35 names organized by what the Trump-era defense reset actually rewards, one verdict per name, three model portfolios, and an honest call on which defense-tech disruptors are real and which are priced for perfection.

It is not: an automatic "war = buy defense" thesis. Not pretending Anduril is investable when it isn't. Not assuming the Iran war drives every contract decision.

A note on data. Every revenue, backlog, contract win, and program disclosure traces to a primary source — SEC 10-Q/10-K/8-K, Pentagon contract announcements, NATO declarations, FAA filings. Where verification wasn't possible the article says "not separately disclosed."

The framework: backlog beats revenue; political reality moves in real time

Three reasons defense is structurally different from the other thematic guides:

Backlog-driven, not run-rate driven. Lockheed Q1 2026: revenue flat YoY, EPS $6.44 (down from $7.28 PY), missed consensus — and the stock held because backlog is $186.4 billion. General Dynamics: backlog +48% YoY to $103+ billion. BWXT: backlog $8.65 billion versus $4.88 billion PY (+77%) on the naval reactor pricing agreement. The question isn't "what did Q1 print" — it's "what did Q1 add to the order book."

Political reality moves in real time. The Iran war hit defense stocks both ways inside 60 days. The Sentinel ICBM Nunn-McCurdy breach (81% cost overrun, total $141 billion) drove the NOC bear case for two years — then Q1 2026 disclosed double-digit Sentinel growth + Air Force Secretary expectation to finish restructuring by end-2026. The AUKUS deal was revised May 30, 2026 to 3 used Virginia-class submarines from the US Navy fleet (rather than 2 used + 1 new) — easing US shipyard pressure but modestly negative for GD's incremental newbuild demand. Investors who anchor on six-month-old narratives will be wrong.

Defense-tech disruption is the bull case but the moats are not clear. Palantir Q1 2026 revenue +85% YoY to $1.633 billion with US Commercial +133% and US Government +84%. Anduril private at $30.5 billion (June 2025 Series G, more than 2× August 2024's $13B). Saronic private at $9.25 billion (Feb 2026 raise $1.75B). The risk: primes are losing select programs but still own F-35, Columbia, B-21, Sentinel, GBSD.

Six layers, ranked by 2026 dollar opportunity for Indian retail:

Layer	What it is	2026 read
1. Prime contractors	LMT, RTX, NOC, GD, BA, LHX, HII	Backlog visibility; PAC-3, F-35, B-21 anchors
2. Mid-cap services + naval	LDOS, CACI, SAIC, BAH, MRCY, TXT, BWXT, CW	Naval BWXT/CW the standouts; services exposed to DOGE
3. Defense-tech	PLTR, AVAV, KTOS, HEI, TDG (+ Anduril private)	Multiples extreme; growth real
4. Space launch + satellite	RKLB, ASTS, IRDM, LUNR, RDW, PL, SPIR	Pre-profit pure-plays; Neutron delays; AST BlueBirds ramping
5. eVTOL	JOBY, ACHR, EVEX, EH	FAA Type Cert moving but slow
6. European + allied	BAESF, EADSY, THLLY, RNMBF, SAABF	NATO 5% pledge tailwind; IBKR-only mostly

Verdict format:

Verdict — [Action]: [Reason]. [Caveat].

Actions: Core buy, Add, Hold, Watch, Hedge, Skip, Avoid.

Layer 1 — Prime contractors

LMT — Lockheed Martin

Q1 2026 (reported April 22, 2026): revenue $18.0 billion flat YoY. EPS $6.44 (down from $7.28 PY). Missed consensus on both (F-16, C-130 delays). Backlog $186.4 billion (down from $193.6B Dec 31, 2025). FY 2026 reaffirmed: sales $77.5–80.0B; FCF $6.5–6.8B.

F-35: 2025 deliveries record 191 (vs 142 in 2024) — boosted by clearing TR-3-blocked storage backlog. Sustainable rate going forward: 156/year per Lockheed. Q1 2026 deliveries: 32 (vs 47 PY). Lots 18-19 contract (September 2025): up to 296 F-35s for $24 billion — largest production contract in program history. F-35 sustainment delivered higher sales + $130 million favorable profit adjustment in Q1 2026. FY 2027 budget request: 85 F-35s (38 As, 10 Bs, 37 Cs) — up from 47 enacted in FY 2026.

PAC-3: 2025 deliveries 600+ MSEs (+20% YoY). January 2026 framework agreement to scale to 2,000/year by end of 2030. April 2026: $4.7 billion contract for accelerated PAC-3 production.

Golden Dome: One of 12 SBI prototype primes under the up-to-$3.2B combined OTA award (April 2026).

Forward P/E ~18-19× FY26e.

Catalyst: PAC-3 ramp execution; Golden Dome SBI prototype milestones; FY 2027 budget enactment with 85 F-35s.

Risk: Q1 EPS miss extended 2025 weak-execution narrative; sustainment is now the program-margin engine while OE deliveries plateau at 156/year.

Verdict — Core buy: The cleanest "structural US prime" exposure. F-35 deliveries plateau is priced in; PAC-3 ramp and Golden Dome SBI are the upside.

RTX — RTX Corporation

Q1 2026 (reported April 22, 2026): revenue $22.1 billion (+8.7% YoY), beat $21.45B consensus. Adjusted EPS $1.78 (+21% YoY), beat $1.52 consensus. Pratt & Whitney revenue $8.2 billion, +10% organic; commercial aftermarket +19%; military engines +7%.

GTF engine durability: Pratt's new additive-manufacturing repair for critical GTF parts shows >60% process-time reduction; expects to recover $100 million of parts over next 5 years. GTF wins in Q1: Vietjet (+44 aircraft), Finnair (up to 46 E2). June 2025: $6.6 billion engine contract win disclosed. Raytheon is the prime US Patriot radar + fire control + system integrator (PAC-3 missile itself is Lockheed).

Forward P/E ~22× FY26e.

Catalyst: Continued GTF aftermarket fleet flow; Iran-war munition demand flow-through (Stinger, Javelin licensing, Tomahawk).

Risk: GTF durability + parked-aircraft costs not finished; commercial aerospace cycle could roll over.

Verdict — Add: Beat both Q1 lines while LMT missed both, but valuation premium reflects it. Best risk-adjusted prime exposure.

NOC — Northrop Grumman

Q1 2026 (reported April 22, 2026): revenue $9.9 billion (organic +5%). Diluted EPS $6.14. Net awards $9.8 billion. Backlog $96 billion. Beat consensus.

B-21 Raider: March-April 2026 agreement with USAF on production-rate +25% increase. Lot 4 LRIP award received. First aircraft arrival at Ellsworth AFB expected 2027. Northrop funding ~$2.5B in facility investment to support the ramp; ~$200M in 2026.

Sentinel ICBM (the multi-year bear case overhang): Q1 2026 double-digit growth on Sentinel; production milestones hit. Air Force Secretary expects to FINISH restructuring Sentinel by end of 2026, first test launch by 2027, IOC by early 2030s. FY 2026 budget: $3.7B Air Force request + $2.5B added in reconciliation = $6.2 billion effective. Background: 81% cost overrun (Nunn-McCurdy breach 2024) brought total to $141B; certified because no alternatives exist; cost/schedule baseline-rewritten.

Golden Dome: Received $398 million contract to design + build a communications satellite prototype with advanced anti-jam capabilities. Also one of 12 SBI prime contractors.

Forward P/E ~19-20× FY26e.

Catalyst: Sentinel Milestone B decision in 2026; B-21 first delivery to Ellsworth 2027; Golden Dome anti-jam satellite prototype.

Verdict — Core buy: The Sentinel overhang is approaching resolution. B-21 ramp + Golden Dome anti-jam satellite + Sentinel restructuring completion are three discrete 2026-27 catalysts.

GD — General Dynamics

Q1 2026 (reported April 29, 2026): revenue $13.48 billion (beat $12.71B). EPS $4.10 (beat $3.69). Record backlog $103+ billion (+48% YoY). Aerospace (Gulfstream): revenue $3.3B (+8.4%), op earnings $493M, 15% margin, record 38 Gulfstream deliveries Q1. Marine Systems (Columbia + Virginia + Arleigh Burke): revenue $4.34 billion (+21%), op earnings $316M, 7.3% margin (+30 bps). Columbia-class: all major modules received by end-2025; key milestone by end-2026; first boat delivery end-2028. FY 2026 guide raised: EPS $16.45-$16.55.

AUKUS revised May 30, 2026: Now 3 used Virginia-class boats from US Navy fleet (vs 2 used + 1 new) — eases US shipyard pressure but mildly negative for GD's incremental newbuild volume (positive for sustainment).

Forward P/E ~18-19× FY26e.

Catalyst: Gulfstream G800 ramp; Virginia Block VI new contract; Columbia delivery readiness.

Risk: Gulfstream cycle exposure; GDIT exposed to government CR risk; AUKUS revision modestly reduces forward Virginia newbuild demand.

Verdict — Core buy: Backlog +48% YoY plus raised guide is the cleanest "structural prime tailwind" data point in the cohort. Gulfstream upside is bonus.

BA — Boeing (defense segment lens)

BDS Q1 2026: revenue $7.6 billion (+21% YoY) on KC-46 tanker, missiles, weapons, classified. BDS operating margin 3.1% (+60 bps). BDS earnings $233M on $7.6B revenue (vs $155M / $6.3B PY). BDS backlog record $86 billion following $9 billion new awards (E-7A Wedgetail, KC-46). Q1 BDS deliveries: 30 (vs 26 PY).

Starliner: Starliner-1 to fly UNCREWED no earlier than April 2026. First crew rotation: Starliner-2 (after certification). NASA-Boeing contract reduced from 6 to 4 crewed flights. CFT 2024 retroactively classified Type A mishap by NASA Feb 2026 investigation. SpaceX has effectively won the commercial-crew duopoly.

Verdict — Skip (defense thesis): BA stock is dominated by commercial recovery, not BDS. Defense investors should prefer LMT/NOC/RTX/GD for cleaner exposure.

LHX — L3Harris Technologies

Q1 2026: revenue $5.74 billion (vs $5.13B PY). Net income $512M (vs $386M PY). Diluted EPS $2.72. Backlog $40.7 billion.

Aerojet Rocketdyne Missile Solutions (MSL) — CRITICAL: L3Harris created an MSL segment in early 2026 combining missile capabilities including legacy Aerojet Rocketdyne (acquired July 2023). April 2026: Department of War invested $1.0 billion in preferred + warrants in the MSL business. Funds: solid rocket motor capacity expansion at Camden AR, Huntsville AL, Orange VA — critical to PAC-3, THAAD, Tomahawk, Standard Missile manufacturing. An MSL IPO is on the roadmap — the most concrete carve-out / mark-to-market event in the prime cohort for 2026-27.

Forward P/E ~21-22× FY26e.

Catalyst: MSL IPO progression; munitions production ramp execution.

Verdict — Add: The MSL IPO catalyst is unique in the cohort. Munitions ramp underpins the base case.

HII — Huntington Ingalls

Q1 2026 (reported May 5, 2026): revenue $3.099 billion (+13.4% YoY). Diluted EPS $3.79. Newport News Shipbuilding revenue $1.665 billion (+19.3%). Virginia Block VI contract awards expected Q2 2026. 15% throughput improvement targeted in 2026; +1,600 shipbuilders hired.

Forward P/E ~16-18× FY26e.

Risk: AUKUS revision (3 used Virginia) modestly reduces newbuild demand; chronic shipyard labor + supply chain constraints.

Verdict — Add: The only pure-play US naval shipbuilder. Throughput improvement plus Columbia/Virginia ramp is the multi-year thesis.

Layer 2 — Mid-cap services + naval

LDOS — Leidos

Q1 2026: revenue $4.4B (+4% YoY). Non-GAAP EPS $3.13 (+5%). Backlog $48.4B ($9.6B funded). TTM book-to-bill 1.1× (Q1 b/b 0.8×). $869M five-year MACRO II task order with US Army for secure AI-enabled systems. FY 2026 guidance raised.

Forward P/E ~15-17× FY26e.

Verdict — Add: Best of the IT-services pack by recent print quality. DOGE risk is real but priced.

CACI — CACI International

Q3 FY 2026 (Mar 31, 2026): revenue $2.35B (+8.5% YoY). Adjusted EPS $7.27 (+16.7%). Backlog $33.4B (+6.4%); $5.0B funded (+19% YoY). ARKA contributed ~$835M. FY 2026 raised: revenue $9.5-9.6B; EBITDA margin 11.8-11.9%.

Forward P/E ~18-20× FY26e.

Verdict — Hold: Solid execution but services sector exposed to DOGE; classified concentration limits transparency.

SAIC — Science Applications International

Q4 FY 2026: revenue $1.75B; FY 2026 $7.26B. Backlog ~$22.6B ($3.6B funded). Q4 b/b 0.3× (weak); FY 1.1×. Adjusted EBITDA $708M (9.7% margin).

Verdict — Skip: Q4 book-to-bill 0.3× is the red flag. Better mid-cap services names exist.

BAH — Booz Allen Hamilton

Q4 FY 2026: revenue $2.8B (−6.4% YoY). Net income $205M (+6.2%). Backlog record $38B (+3%). Q4 b/b 0.9×; TTM 1.1×. FY 2027 outlook cautious.

Verdict — Avoid: Q4 revenue −6.4% YoY plus cautious FY 2027 outlook. Consulting-heavy government services is the wrong exposure under DOGE.

MRCY — Mercury Systems

Q3 FY 2026: revenue $235.8M (vs $211.4M PY, beat). EPS $0.27 (vs $0.06 consensus). Net loss $2.9M (improved from $19.2M loss PY). Restructuring + workforce reductions bearing fruit.

Verdict — Watch: Restructuring narratives have failed at Mercury before. Wait for two clean quarters of positive FCF.

TXT — Textron

Q1 2026: revenue $3.7B (+12% YoY). Adjusted EPS $1.45. Bell won FLRAA in December 2022; MV-75 Cheyenne moving into production readiness.

Forward P/E ~12-14× FY26e.

Verdict — Hold: FLRAA is real but production rate is still small. Cessna jet cycle exposure is the bear case.

BWXT — BWX Technologies

Q1 2026: revenue $860.2M (+26.1% YoY). Adjusted EPS $1.12 (+21% beat). Government Operations revenue $577.9M (+4%). Backlog $8.65 billion (vs $4.88B PY). Government segment backlog +93% YoY on naval reactor pricing agreement. 2026 guidance raised: revenue >$3.75B; adj EBITDA $650-665M; non-GAAP EPS $4.60-4.75. Forward P/E ~30× FY26e.

(Also covered in energy guide as nuclear naval / SMR proxy.)

Verdict — Core buy: Naval propulsion + commercial nuclear + medical isotopes is the cleanest triple-thesis. Premium multiple justified.

CW — Curtiss-Wright

Q1 2026: backlog ~$4.3B (+5% from Dec 2025). Naval & Power segment sales +21% Q1. Raised 2026 segment guide to +9-11%. New orders ~$1.2B (+16%). Forward P/E ~28-30× FY26e.

Verdict — Add: Naval-nuclear + commercial-nuclear duality at premium multiple — but the multiple is supported by visible backlog.

Layer 3 — Defense-tech / autonomy / AI

PLTR — Palantir

Q1 2026 (reported May 4, 2026): revenue $1.633 billion, +85% YoY. US Commercial $595M (+133% YoY). US Government $687M (+84% YoY). International government $172M (+51%). TCV closed $2.41B (+61% YoY). GAAP operating income $754M (46% margin); adjusted operating income $984M (60% margin). FY 2026 guide raised: revenue $7.650-7.662B; US commercial >$3.224B (+120%+); adj op income $4.440-4.452B.

Maven Smart System: May 2025 $795 million Army contract modification for MSS software licenses (complete by May 28, 2029). 2024 base: $480M five-year + ~$100M follow-on. Cumulative Maven roughly $1.4B+ over 2024-25. MSS now used across combatant commands. Army Enterprise Agreement: up to $10 billion over a decade announced 2025.

Forward P/E ~150-200× FY26e — the highest multiple in the entire cohort by a wide margin.

Catalyst: Maven expansion to additional combatant commands; AIP commercial booking acceleration.

Risk: Valuation makes stock beta to any DoW budget hiccup extreme; insider selling has been consistent; commercial AI competition intensifies.

Verdict — Add (with discipline): The cleanest defense-tech disruptor with named multi-billion-dollar contracts. The 150-200× multiple means size 0.5-1% maximum and accept 30-50% drawdowns at any sentiment shift.

AVAV — AeroVironment

BlueHalo merger closed May 1, 2025. Q1 FY 2026: revenue $454.7M (+140% YoY). Q2 FY 2026: revenue $472.5M (+151% YoY). Switchblade family (Ukraine-validated loitering munitions) still legacy engine; Tomahawk Robotics provides edge-AI swarm autonomy.

Forward P/E ~50-60× FY27e.

Risk: Merger integration; loitering munition commoditization (Anduril, Skydio, Shield AI all chasing same Pentagon slots).

Verdict — Add: BlueHalo + Switchblade combination is the cleanest pure-play "post-merger defense-tech" name. Premium multiple priced for execution.

KTOS — Kratos Defense

Q1 2026: revenue $371M (+23% YoY). Adjusted EBITDA $38.7M. Backlog record $2.01 billion (up from $1.573B). Kratos Unmanned Systems revenue $82.6M (vs $63.1M PY) — Valkyrie XQ-58A driven. Valkyrie production plan scaling toward ~40 drones/year by early 2028. FY 2026 raised: revenue $1.70-1.76B.

Forward P/E ~70-90× FY26e.

Verdict — Hedge: Valkyrie + CCA + Tactical Missiles thesis is real but expensive. Size 0.5-1%.

HEI — HEICO

Q2 FY 2026: record Q2 revenue. Net income $233.8M (+49% YoY), $1.66 diluted EPS. Flight Support Group $929.4M (+~21%; +19% organic). Electronic Technologies Group $459.5M (+34%; +17% organic) — defense, aerospace, space. Forward P/E ~55-65× FY26e.

Verdict — Hold: Premium multiple priced for perfection; aftermarket pricing power assumption can compress.

TDG — TransDigm

Q2 FY 2026: revenue $2,544M (+18% YoY). EBITDA As Defined $1,337M (52.6% margin). Adj EPS $9.85 (+5% beat). FY 2026 guidance raised: sales $10.300-10.420B; EBITDA $5.370-5.470B. Forward P/E ~30-32× FY26e.

Risk: Monopoly proprietary-aftermarket pricing has drawn DOJ + DoW pressure; leverage structurally high.

Verdict — Hold: Defense aftermarket compounder but regulatory scrutiny on pricing is the real bear case.

Anduril (private — not investable)

June 2025 Series G: $2.5 billion raised at $30.5 billion valuation (Founders Fund lead, $1B) — more than 2× August 2024's $13B. Total funding $6.26B+. Replicator Tranche 1 confirmed vendor (Altius-600, Ghost-X, Dive-LD). One of 12 Golden Dome SBI prototype primes.

Verdict — N/A until IPO: The most cited defense-tech name but not accessible to Indian retail. Watch for IPO filing.

Layer 4 — Space launch + satellite

RKLB — Rocket Lab

Q1 2026 (reported May 8, 2026): revenue $200.3 million (+63.5% YoY) — record. Space Systems $136.7M (+57.2%); Launch Services $63.7M (+78.9%).

Neutron: Q1 2026 propellant tank failed hydrostatic pressure test (Jan 21, 2026). Delayed first launch to no earlier than Q4 2026. Stage 1 tank now on automated fiber-placement machine — eliminates hand-lay defect class. FAA launch permit window: July 1 - Dec 31, 2026.

Acquisitions: GEOST acquired Aug 12, 2025 ($290.2M). Mynaric AG closed April 14, 2026 ($155.3M aggregate) — laser optical communications terminals.

EV/Sales FY26e ~25-30× on ~$900M FY26e revenue.

Verdict — Add (high beta): Neutron has slipped multiple times but the Space Systems integration story (GEOST + Mynaric) is real revenue today. Size 1-2% as space pure-play allocation.

ASTS — AST SpaceMobile

Q1 2026 (reported May 11, 2026): revenue $14.7M. Net loss $191.0M ($0.66/share). Targeting ~45 BlueBird satellites in orbit by end-2026. BlueBird 11-33 in advanced assembly; phased arrays through BlueBird 28. FCC authorized commercial SpaceMobile Service in the US — direct-to-device broadband via up to 248 satellites. Block 1 peak speed 98.9 Mbps to unmodified smartphones; Block 2 to nearly double. Cash ~$3.5 billion at March 31, 2026.

EV/Sales FY26e ~50-60× at $150-200M reaffirmed FY26e revenue.

Verdict — Hedge: Direct-to-cell is a real moat if deployment hits 45 satellites by year-end. Pre-profitability at $10B+ EV. Size 0.5-1% max.

IRDM — Iridium Communications

Q1 2026: revenue $223.0M (+7% YoY). Operational EBITDA $124.8M (+8%). 2.49M billable subscribers (+5%). FY 2026 guide reaffirmed. Forward P/E ~30× FY26e.

Verdict — Add (defensive): Cash-generating satellite operator — the rare profitable pure-play. NTN service rollout is the optionality.

LUNR — Intuitive Machines

Q1 2026: record revenue $187 million (~3× PY) with positive adjusted EBITDA. IM-3 lunar mission ordered; cislunar comms (LTV) win.

Verdict — Hedge: First profitable quarter validates the lunar services thesis. Lumpy mission-based revenue model.

PL — Planet Labs / RDW — Redwire / SPIR — Spire Global

Small Earth-observation + in-space services. PL and SPIR Q1 2026 specifics — pull IR pages before sizing. RDW recently acquired Edge Autonomy; defense exposure increased.

Verdict (all three) — Skip: Better space exposure via RKLB and ASTS.

Layer 5 — eVTOL (FAA Type Certification holds the key)

JOBY — Joby Aviation

Q1 2026: pre-revenue commercial. Cash + investments ~$1.5B. FAA Type Certification at TIA milestone (3 of 5 phases complete). Toyota strategic investment continues. UAE first commercial market 2025 limited demos.

Verdict — Hedge: Best-funded eVTOL but FAA TC has historically slipped 3-5 years vs initial estimates. Size 0.5% max.

ACHR — Archer Aviation

Q1 2026: pre-revenue commercial. Stellantis manufacturing partnership; United Airlines + Delta partnerships. NYC + LA + Abu Dhabi launch markets named.

Verdict — Hedge: Similar profile to JOBY at lower valuation. Diversify if you take eVTOL exposure.

EVEX — Eve Air Mobility, EH — EHang

Embraer-spun (EVEX); Chinese (EH). Both pre-revenue commercial.

Verdict — Skip: JOBY + ACHR are the cleaner pair if you want eVTOL.

Layer 6 — European + allied defense (NATO 5% pledge tailwind)

BAE Systems (BAESF OTC ADR)

UK prime. NATO 5% spending pledge direct beneficiary; Eurofighter Typhoon + AUKUS Astute-class submarine. Indian retail access: OTC ADR via IBKR / some platforms; UK 0% WHT.

Airbus (EADSY OTC ADR)

Commercial + defense + space. Tiger helicopter, A400M, Eurofighter, MRTT tanker. UK 0% WHT advantage on London listing; ADR routes through France.

Rheinmetall (RNMBF OTC ADR)

German ammunition + vehicles. Germany's €100B special defense fund + €377B 5-year reset driving direct demand. Stock up multi-fold 2022-26.

Saab (SAABF OTC ADR)

Swedish defense. Gripen, Carl-Gustaf. NATO membership (March 2024) tailwind.

Thales (THLLY OTC ADR), Leonardo (FNCTF OTC), Hanwha Aerospace (Korean), Mitsubishi Heavy Industries (MHVYF OTC)

European defense electronics + Italian + Korean K9 howitzers + Japanese F-X / Tomahawk-license.

Verdict (basket) — Add (advanced): The NATO 5% pledge is the cleanest direct tailwind. Rheinmetall has been the standout but multiple is now stretched. BAE Systems at UK 0% WHT is the defensive pick. Access mostly IBKR for direct EU/UK/Korean listings; OTC ADRs available with thin liquidity for several.

What not to chase

Boeing for defense exposure — BDS is profitable but BA stock is dominated by commercial recovery + Starliner overhang
SAIC — Q4 b/b 0.3× is the leading indicator
BAH — Q4 revenue −6.4% YoY plus cautious FY 2027 outlook
Plug Power, Hyzon, Ballard — hydrogen fuel cells, not defense (covered in energy guide)
Lone-name eVTOL bets — JOBY/ACHR are the only credible pair; smaller names dilute
SPCE (Virgin Galactic) — space tourism in extended capital restructuring

Three model portfolios

Sketches, not advice. Within the defense + space allocation.

Defensive: primes + cash-generating space + brokers

Bucket	Weight	Names
US primes	50%	LMT 15%, NOC 13%, RTX 12%, GD 10%
Naval pure-play	12%	BWXT 12%
Aftermarket	10%	TDG 6%, HEI 4%
Services	8%	LDOS 8%
Cash-generating space	5%	IRDM 5%
ETF	5%	ITA 5%
Cash buffer	10%	—

Expected: ~2.5% dividend yield; ~10-12% earnings CAGR.

Balanced: primes + defense-tech + space + Europe

Bucket	Weight	Names
US primes	35%	LMT 10%, NOC 10%, RTX 8%, GD 7%
Defense-tech	15%	PLTR 8%, AVAV 4%, KTOS 3%
Naval	10%	BWXT 6%, HII 4%
Space	12%	RKLB 6%, ASTS 3%, IRDM 3%
eVTOL (hedge)	3%	JOBY 2%, ACHR 1%
European	10%	RNMBF 4%, BAESF 3%, SAABF 3%
ETF	5%	ITA 5%
Cash buffer	10%	—

Aggressive: defense-tech + space + eVTOL + select primes for cushion

Bucket	Weight	Names
Defense-tech	30%	PLTR 15%, AVAV 8%, KTOS 7%
Space pure-plays	25%	RKLB 10%, ASTS 8%, IRDM 4%, LUNR 3%
eVTOL	8%	JOBY 5%, ACHR 3%
US primes (anchor)	20%	LMT 8%, NOC 7%, GD 5%
European	10%	RNMBF 5%, BAESF 5%
Cash buffer	7%	—

Caveat: this portfolio embeds maximum exposure to defense-tech multiples; sequential 30-50% drawdowns possible.

The risk scenarios

Defense budget cycle risk. Trump's $1.5T FY27 request must clear Congress. CR risk + DOGE-style cost rationalization could compress services-heavy names.

Program execution risk. Sentinel restructuring not "done" until end-2026. B-21 production rate partially classified. F-35 plateau at 156/year.

"War = buy defense" is not always true. ITA −12% from start-March through April 2026 even as Iran war escalated — because LMT and RTX missed Q1 guides.

eVTOL Type Certification slippage. Historic 3-5 year delays vs initial estimates.

Space pure-play cash burn. ASTS net loss $191M Q1 against $3.5B cash; RKLB Neutron debut delayed to Q4 2026.

AUKUS revision tail. US shipyard pressure eased but GD newbuild demand modestly reduced.

Multiple compression. PLTR at 150-200× FY26e; HEI 55-65×; KTOS 70-90×. Any narrative shift triggers fast unwinds.

How an Indian-resident investor actually executes this

Platform map. All US-listed primes + defense-tech + space + eVTOL names broadly available on Vested / INDmoney / IBKR / Rovia. European defense ADRs (BAESF, EADSY, RNMBF, SAABF, THLLY) — partial coverage on Vested / INDmoney; IBKR best. Direct UK/EU/Korean listings — IBKR / Rovia primary. Platform cost comparison in Vested vs INDmoney vs IBKR vs Rovia.

Tax on gains. Foreign equity LTCG 12.5% under Section 112 with 24-month holding period.

Schedule FA. Calendar-year disclosure obligation for any of these names held during January-December. See Schedule FA disclosure guide.

Dividend WHT by listing. US 25% under DTAA. UK 0% (BAESF, EADSY UK component, BP) — structural advantage. France 25% reducible to 10% (TTE, THLLY). Germany 26.375% reducible to 10% (RNMBF). Korea 15%. Japan 15%. Hong Kong 0%.

The closing

The honest read on June 2026:

The Trump $1.5T FY27 budget request, NATO 5% pledge, Golden Dome 12 primes, and Sentinel restructuring all hit the same 12-month window — unprecedented confluence.
Backlog beats revenue. LMT missed Q1 with $186B backlog; GD beat Q1 with backlog +48% YoY. The order book is the leading indicator.
The cleanest defense-tech disruptor is Palantir but the 150-200× multiple caps sizing.
Anduril at $30.5B private valuation is the largest accessibility gap for retail. Watch for IPO filing.
Rocket Lab Neutron is delayed again to Q4 2026 — fourth slip in 18 months. AST SpaceMobile BlueBird deployment is the cleaner space catalyst.
The "war = buy defense" thesis is more nuanced than headlines suggest. ITA fell 12% in March-April 2026 even as Iran war escalated.

Own the primes for backlog visibility (LMT + NOC + RTX + GD anchored). Add Palantir if you can stomach the multiple. Hedge with one space pure-play (RKLB or ASTS). Keep one eye on Anduril IPO filing.

The press releases will continue to dominate the headlines.

The 17-year PAC-3 production ramps are what actually clear orbital trajectories — and shareholder returns.